Rauhala Minna, Luoto Teemu M, Huhtala Heini, Iverson Grant L, Niskakangas Tero, Öhman Juha, Helén Pauli
1Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere.
2Faculty of Social Sciences, Biostatistics Group, Tampere University, Tampere, Finland.
J Neurosurg. 2019 Mar 22;132(4):1147-1157. doi: 10.3171/2018.12.JNS183035. Print 2020 Apr 1.
The aim of this study was to determine the population-based epidemiology of chronic subdural hematoma (CSDH) over a 26-year period.
A retrospective study was conducted of all adult patients (≥ 18 years and residents of Pirkanmaa [Finland]) with a diagnosis of CSDH between 1990 and 2015. The cases were identified using ICD codes. Detailed data collection was performed using medical records and death certificates. All patients were monitored until death or the end of year 2017. The annual number of inhabitants in the Pirkanmaa region was obtained from Statistics Finland (Helsinki, Finland).
A total of 1168 patients with CSDH were identified from hospital records and death certificates; patients were considered as new-incidence cases if 2 years had elapsed following primary treatment and in cases involving a new contralateral CSDH. From 1990 to 2015, the overall incidence of CSDH doubled from 8.2 to 17.6/100,000/year. Among adults younger than 70 years, the incidence remained quite stable, whereas the incidence clearly increased among the ≥ 80-year-old population, from 46.9 to 129.5/100,000/year. The median age for a CSDH diagnosis increased from 73 to 79 years during the 26-year period. Head trauma was documented in 59% of cases. A ground-level fall was related to the CSDH in 31% of patients younger than 60 years and in 54% of those 80 years or older. The proportion of alcohol-related cases decreased toward the end of the study period (1990-1995: 16% and 2011-2015: 7%), because alcohol abuse was less frequent among the growing group of elderly patients. In contrast, the percentage of patients receiving anticoagulant or antiplatelet medication almost doubled toward 2015 (1990-1995, 27%; and 2011-2015, 49%). The patients' neurological condition on admission, based on both Glasgow Coma Scale score (score < 13: 1990-1995, 18%; and 2011-2015, 7%; p < 0.001) and the modified Rankin Scale score (score 0-2: 1990-1995, 8%; and 2011-2015, 19%; p < 0.001), was better in recent years than in the early 1990s.
From 1990 to 2015, the incidence of CSDH has increased markedly. The incidence of CSDH among the population 80 years or older has nearly tripled since 1990. The use of anticoagulants has increased, but there has been no change regarding the ratio between a traumatic and a spontaneous CSDH etiology. As the world population becomes progressively older, the increasing incidence of CSDH will be a burden to patients and a future challenge for neurosurgical clinics.
本研究旨在确定26年间慢性硬膜下血肿(CSDH)的基于人群的流行病学特征。
对1990年至2015年间所有诊断为CSDH的成年患者(≥18岁且为皮尔卡区[芬兰]居民)进行回顾性研究。使用国际疾病分类代码识别病例。通过病历和死亡证明进行详细的数据收集。对所有患者进行监测直至死亡或2017年底。皮尔卡区的年居民人数来自芬兰统计局(芬兰赫尔辛基)。
从医院记录和死亡证明中总共识别出1168例CSDH患者;如果初次治疗后已过去2年以及涉及对侧新发CSDH的病例,则将患者视为新发病例。1990年至2015年,CSDH的总体发病率从8.2/10万/年增加了一倍,达到17.6/10万/年。在70岁以下的成年人中,发病率保持相当稳定,而在80岁及以上人群中,发病率明显增加,从46.9/10万/年增至129.5/10万/年。在这26年期间,CSDH诊断的中位年龄从73岁增加到79岁。59%的病例有头部外伤记录。在60岁以下的患者中,31%的CSDH与地面跌倒有关,在80岁及以上的患者中,这一比例为54%。与酒精相关的病例比例在研究期结束时下降(1990 - 1995年:16%;2011 - 2015年:7%),因为在老年患者不断增加的群体中,酒精滥用情况减少。相比之下,到2015年接受抗凝或抗血小板药物治疗的患者百分比几乎翻了一番(1990 - 1995年,27%;2011 - 2015年,49%)。根据格拉斯哥昏迷量表评分(评分<13:1990 - 1995年,18%;2